Related Experiment Videos
[Hypertension in the Negro patient]
G J Timmers1, J A Schouten, P M ter Wee
1Academisch Ziekenhuis Vrije Universiteit, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|March 23, 1999
Summary
Essential hypertension is more common and starts earlier in Black individuals. Aggressive treatment, often starting with diuretics, is recommended due to increased complication risks.
Area of Science:
- Cardiology
- Nephrology
- Genetics
Background:
- Essential hypertension is more prevalent in Black populations, with earlier onset and more severe complications like heart, kidney, and cerebrovascular diseases.
- Differences in hypertension prevalence and complications between Black and White individuals may stem from genetic and environmental factors.
Purpose of the Study:
- To explore the unique characteristics of hypertension in Black individuals.
- To discuss potential contributing factors, including genetic, environmental, and socioeconomic variables.
- To recommend tailored antihypertensive therapeutic strategies for Black patients.
Main Methods:
- Review of existing data and studies focusing on hypertension in the African-American population.
- Analysis of physiological characteristics such as salt sensitivity, plasma volume, and renin levels.
- Evaluation of treatment responses to various antihypertensive medications.
Main Results:
- Hypertension in Black individuals is associated with salt sensitivity, expanded plasma volume, and low plasma renin.
- Obesity, insulin resistance, and socioeconomic factors may contribute to higher hypertension prevalence.
- Black patients often show reduced responsiveness to monotherapy with ACE inhibitors and beta-blockers, but this can be overcome with diuretics.
Conclusions:
- Aggressive antihypertensive therapy, potentially with lower blood pressure goals, is crucial for Black patients.
- Diuretic monotherapy is recommended as first-line treatment, with calcium channel blockers as alternatives.
- Combination therapy, particularly including a diuretic, can improve treatment response in Black patients often less responsive to other agents.